The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Aberrant synaptic plasticity, originating from abnormalities in dopamine and/or glutamate transduction pathways, may contribute to the complex clinical manifestations of bipolar disorder (BD). Dopamine and glutamate systems cross-talk at multiple levels, such as at the postsynaptic density (PSD). The PSD is a structural and functional protein mesh implicated in dopamine and glutamate-mediated synaptic plasticity. Proteins at PSD have been demonstrated to be involved in mood disorders pathophysiology and to be modulated by antipsychotics and mood stabilizers. On the other side, post-receptor effectors such as protein kinase B (Akt), glycogen synthase kinase-3 (GSK-3) and the extracellular signal-regulated kinase (Erk), which are implicated in both molecular abnormalities and treatment of BD, may interact with PSD proteins, and participate in the interplay of the dopamine–glutamate signalling pathway. In this review, we describe emerging evidence on the molecular cross-talk between dopamine and glutamate signalling in BD pathophysiology and pharmacological treatment, mainly focusing on dysfunctions in PSD molecules. We also aim to discuss future therapeutic strategies that could selectively target the PSD-mediated signalling cascade at the crossroads of dopamine-glutamate neurotransmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 2×
“…the phosphatidylinositol3-kinase kinase, PI-3K, pathway) and is involved in multiple cellular processes, including metabolism, proliferation, differentiation, synaptogenesis, neuroplasticity, and apoptosis (Doble and Woodgett, 2003; Frame and Cohen, 2001; Jope and Johnson, 2004; Kim et al., 2006).”
BackgroundGSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Sweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131 · cited 2×
“…involved in multiple cellular activities, including the modulation of transcription factors (i.e. p62 ternary complex factor (Elk1); cyclic AMP response element binding, CREB) that regulate the expression of cellular genes essential for cell survival mechanisms (Sweatt, 2001; Wang et al., 2004).”
BackgroundDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 1×
“Moreover, favourable therapeutic effects have been observed in a randomized trial of ketamine add-on treatment to lithium or valproate in patients suffering from bipolar depression (Diazgranados et al., 2010).”
BackgroundDopaminergic modulation of synaptic transmission in cortex and striatum
Tritsch, N. X., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.023 · Cited by 756
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 2×
“…such as amphetamines, has been reported to induce mania-like symptoms in healthy subjects (Anand et al., 2011; Asghar et al., 2003; Jacobs and Silverstone, 1986; Vollenweider et al., 1998), putatively as a consequence of dopamine release in the anteroventral striatum (Drevets et al., 2001).”
BackgroundEmotional bias and inhibitory control processes in mania and depression
MURPHY, F. C., SAHAKIAN, B. J., RUBINSZTEIN, J. S., MICHAEL, A., ROGERS, R. D., ROBBINS, T. W., & PAYKEL, E. S. (1999) · Psychological Medicine · doi:10.1017/s0033291799001233 · Cited by 659
The Shank family of scaffold proteins
Sheng, M., & Kim, E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1851 · Cited by 578
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456 · cited 1×
“…been observed that Erk1 knockout mice display several behavioural mania-like manifestations, such as increased activities in a novel environment (Mazzucchelli et al., 2002), reduced immobility in the forced swim test, hyperlocomotion in the open field test, persistently increased home-cage…”
Background
Cited by
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Benedetti, F., Poletti, S., Locatelli, C., Mazza, E., Lorenzi, C., Vitali, A., Riberto, M., Brioschi, S., Vai, B., Bollettini, I., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.011 · Cited by 64
“Gene variants affecting monoaminergic neurotransmission and glutamate can influence it (Benedetti et al., 2015a), and Homer1 is involved in dopamine- and serotonin- glutamate cross–talk (de Bartolomeis et al., 2013; de Bartolomeis et al., 2014).”
Parekh, P. K., Becker-Krail, D., Sundaravelu, P., Ishigaki, S., Okado, H., Sobue, G., Huang, Y., & McClung, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.022 · Cited by 48
“Recently, BD has been re-conceptualized by some as a synaptic disorder where the functions of postsynaptic proteins are altered in prefrontal and striatal regions, potentially producing circuit-level consequences affecting normal mood and reward response (10; 11).”
Metadata
- Authors
- de Bartolomeis, A., Buonaguro, E. F., Iasevoli, F., & Tomasetti, C.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-02-19
- Volume
- 28
- Issue
- 6
- Pages
- 505-526
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2128200158
- Cited by
- 44
- References
- 40
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. https://app.cochat.ai/papers/10.1177/0269881114523864
- The paper
- de Bartolomeis, A., Buonaguro, E. F., Iasevoli, F., & Tomasetti, C. (2014). The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114523864
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.